A second pivotal multi-center, randomized controlled study evaluating SkinTE in the treatment of Treatment of Venous Leg Ulcers
Latest Information Update: 18 Aug 2022
At a glance
- Drugs Autologous cell therapy-PolarityTE (Primary)
- Indications Leg ulcer
- Focus Registrational; Therapeutic Use
- Sponsors PolarityTE
Most Recent Events
- 11 Aug 2022 According to a PolarityTE media release, company plans to follow-up with the FDA regarding the design and implementation of this trial.
- 06 May 2022 According to a PolarityTE media release, this trial is needed to support a biologics license application (BLA) for SkinTE for a chronic cutaneous ulcer indication.
- 28 Feb 2022 New trial record